Effect of Spironolactone on Sex Hormones in Man
The DOI matches its Crossref record.
Abstract
Administration spironolactone at a dosage of 400 mg/day to healthy male volunteers for 5 days resulted in a significant rise in plasma progesterone and 17alpha-hydroxyprogesterone which persisted throughout the study. A transient increase in plasma FSH and LH concentration was observed after the second but not the third or fifth days of drug administration. There was no change in plasma concentration of testosterone, 17beta-estradiol, or prolactin. These findings are consistent with a previously-reported spironolactone-induced destruction of the microsomal enzyme cytochrome P-450, an enzyme necessary for 17-hydroxylase and desmolase activity. The results do not explain the decrease of libido, the impotence, and the gynecomastia frequently associated with spironolactone therapy in males.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
“Spironolactone works by directly blocking androgens during their interaction with the androgen receptor (114, 133, 142).”
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Arroyo, V., & Colmenero, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00007-2 · Cited by 279
Nebert, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1203 · Cited by 276
The endocrine effects of spironolactone used as an antiandrogen
Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59346-7 · Cited by 38
Metadata
- Authors
- STRIPP, B., TAYLOR, A. A., BARTTER, F. C., GILLETTE, J. R., LORIAUX, D. L., EASLEY, R., & MENARD, R. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1975-10
- Volume
- 41
- Issue
- 4
- Pages
- 777-781
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1970734657
- Cited by
- 102
- References
- 0
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Spironolactone on Sex Hormones in Man. https://app.cochat.ai/papers/10.1210/jcem-41-4-777
- The paper
- STRIPP, B., TAYLOR, A. A., BARTTER, F. C., GILLETTE, J. R., LORIAUX, D. L., EASLEY, R., & MENARD, R. H. (1975). Effect of Spironolactone on Sex Hormones in Man. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-41-4-777
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.